New test spots schizophrenia biomarkers

A new test called VeriPsych is designed to highlight biomarkers for schizophrenia that can be found in the blood. Dozens of biomarkers for schizophrenia have been found in recent years. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.